Fiche société
Academic and Community Cancer Research United
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD)The goals of this protocol are to determine the effect of oxaliplatin, cytosine arabinoside, and dexamethasone with Rituxan (ROAD) as treatment for patients with relapsed CD20+ B-cell non-Hodgkins lymphoma (NHL). | SEP | Phase 2 | Immunomodulation | United States | À vérifier |
| Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD)The goals of this protocol are to determine the effect of oxaliplatin, cytosine arabinoside, and dexamethasone with Rituxan (ROAD) as treatment for patients with relapsed CD20+ B-cell non-Hodgkins lymphoma (NHL). | SEP | Phase 2 | Immunomodulation | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) | SEP | Phase 2 | NCT00166439 | Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||